Print this Article
RSSBackchannelmedia
Manhattan Research Offers an In-depth Analysis of Integrated Oncology Consumer Marketing
NEW YORK, March 23 /PRNewswire/ -- Ten years ago no one would have thought we would see the day when advertisements for cancer therapies air in the prime time on network television. However, with the much publicized success of Procrit advertising, today there is a new crop of cancer-related prescription products vying for attention via mass media broadcasting and even more cancer franchises considering how to optimize marketing channels to educate consumers about new treatment options and to ultimately drive more product requests.
As part of its new Consumer Integrated Marketing Analysis (CIMA) product line which is focused on helping targeted therapy biotech and pharmaceutical franchises, Manhattan Research (http://www.manhattanresearch.com/), a marketing services firm, announced today the availability of the Cancer CIMA. Designed to assist marketing executives in their strategic product planning, Cancer CIMA provides an understanding of where the target market is today and, more importantly, where it is headed in the near future by analyzing how patients, information seekers, and caregivers for cancer patients are utilizing a wide range of information sources, including how alternative media channels are becoming the preferred source among patients and caregivers.
"The opportunity to engage, educate, and empower cancer patients has changed significantly over the past several years," states Ashley Wendus, Senior Analyst with Manhattan Research. She continues, "While many therapeutic segments have experienced moderate to no growth with respect to the use of online resources for learning more about treatment options, cancer patients - and their caregivers - have embraced alternative media much faster than the average consumer with a chronic health condition."
CANCER: CONSUMER INTEGRATED MARKETING ANALYSIS - TOPICS EXPLORED
-- Health Information Access (across media and marketing channels)
-- Caregivers and Disease Information Seekers
-- Prescription Drug Profile and Requests
-- Physician Communication and Connectivity
-- DTC Marketing (and response channels)
-- Internet Adoption and Utilization Characteristics
-- Email Marketing and Communication
-- Clinical Trials Information (including portals)
-- Relationship Marketing (and customer service)
-- Rx Information Online (including use of product.com)
-- Health Insurance Profile (including Medicare enrollees)
-- Search Engine Optimization (and satisfaction)
The complete analysis and research findings are immediately available for purchase. For more information on Cancer CIMA and to download a free cancer market snapshot please visit us online at http://www.manhattanresearch.com/CancerCIMA.htm or contact Eric Martin at emartin@manhattanresearch.com or 212-367-8886.
ABOUT MANHATTAN RESEARCH, LLC
Manhattan Research, based in New York, helps healthcare and life sciences organizations adapt, prosper, and maximize opportunities in the networked economy. The company seeks to serve as a strategic positioning system for clients, helping them use industry expertise, robust proprietary data sets, and insight to maximize the value of their overall business strategy. Manhattan Research's clients include global pharmaceutical and biotech companies, nonprofit health organizations, technology vendors, health content providers, and health plans.
Contact Information:
Eric Martin
(212) 367-8886
Source: Manhattan Research
CONTACT: Eric Martin of Manhattan Research, +1-212-367-8886 or emartin@manhattanresearch.com
Web site: http://www.manhattanresearch.com/
